A new blood test that has the potential to diagnose Alzheimer’s disease in an individual and significantly advances drug testing and research on the disease, has been developed. The test, known as I.S. for Immunosignature and developed by a team led by UCLA neurologist Lucas Restrepo, uses a special method of fluorescent tagging of antibodies in the blood to recognize an identifiable binding pattern - or antibody signature - associated with Alzheimers. “This is an important contribution to Alzheimer’s research,” said Rudy Tanzi, chairman of the Cure Alzheimer’s Research Consortium. “We cannot treat what we can’t diagnose, and Alzheimer’s research has been severely restricted by our ability to reliably, consistently and precisely diagnose this disease in all its progressive stages. If these results are confirmed, I.S. could be used to make diagnosis easier and swifter, and for researchers to test potential therapies much faster and more effectively.”
Posted on: Tue, 29 Apr 2014 07:21:41 +0000
Trending Topics
Recently Viewed Topics
© 2015